Latest News in the pharma Industry

Biopharma News

AstraZeneca taps Halix for commercial drug substance manufacture of COVID-19 vaccine

AstraZeneca taps Halix for commercial drug substance manufacture of COVID-19 vaccine

9 Dec 2020

Dutch CDMO will expand with two additional viral vector production lines to meet the increased demand

Read more 
Catalent starts manufacture of Passage Bio's lead gene therapy products

Catalent starts manufacture of Passage Bio's lead gene therapy products

7 Dec 2020

The CDMO will provide packaging, labeling and distribution services through its FastChain demand-led supply offering

Read more 
CPhI Pharma Trends 2021 Report: out now!

CPhI Pharma Trends 2021 Report: out now!

25 Nov 2020

The emerging trends likely to shape the next year for the pharmaceutical manufacturing and outsourcing sectors

Read more 
AZ and Oxford COVID-19 vaccine brings end of pandemic a little closer

AZ and Oxford COVID-19 vaccine brings end of pandemic a little closer

24 Nov 2020

AZD1222 is 90% effective, cheap to produce and easy to store, distribute and administer

Read more 
Alvotech and Yangtze River forge biosimilar deal for Chinese market

Alvotech and Yangtze River forge biosimilar deal for Chinese market

24 Nov 2020

The partnership will focus on commercializing eight biosimilar medicines in China for the domestic market

Read more 
Early trial results hail Moderna's COVID-19 vaccine as 94.5% effective

Early trial results hail Moderna's COVID-19 vaccine as 94.5% effective

17 Nov 2020

Data also show that mRNA-1273 remains stable at 2–8°, the temperature of a standard home or medical refrigerator, for 30 days.

Read more 
Seqirus to build $800m influenza vaccine manufacturing facility in Australia

Seqirus to build $800m influenza vaccine manufacturing facility in Australia

17 Nov 2020

The facility will be the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere.

Read more 
European Commission wraps up CureVac COVID-19 vaccine supply deal

European Commission wraps up CureVac COVID-19 vaccine supply deal

17 Nov 2020

Europeans set to benefit from the EC's authorization of COVID-19 candidate vaccine supply agreement, securing up to 405 million doses of CVnCoV

Read more 
Vibalogics establishes US presence with virotherapy facility in Boston

Vibalogics establishes US presence with virotherapy facility in Boston

16 Nov 2020

The specialist CDMO's $150 million 3-year investment plan will provide a complete suite of virotherapy services to support drug developers and their most "revolutionary" products.

Read more 
Pharmapack Podcast: The opportunities and challenges of bringing connected devices to market in the drug delivery sector

Pharmapack Podcast: The opportunities and challenges of bringing connected devices to market in the drug delivery sector

13 Nov 2020

Smart, connected devices are revolutionizing drug delivery in the ways they can gather, order and transmit crucial patient data to physicians

Read more 
Who are BioNTech?

Who are BioNTech?

12 Nov 2020

CPhI lifts the lid on the relatively little known German biotech and partner of Pfizer behind the most promising COVID19 vaccine candidate

Read more 
Biomanufacturing: a future shaped by evolving markets, technology and global events

Biomanufacturing: a future shaped by evolving markets, technology and global events

12 Nov 2020

Gareth Macdonald

The coronavirus pandemic has impacted biopharmaceutical manufacturing and is likely to continue to do so for years to come. But the pandemic is not the only thing changing how the industry goes about making medicines.

Read more